Patent · US Active

Collagen type X alpha-1 assay

US11531028B2 · kind B2 · utility

0Cited by
1References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 1, 2020
Grant dateDec 20, 2022
Priority date
Expiry dateOct 16, 2040

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/105
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

An antibody specifically reactive with an epitope of collagen type X alpha 1 comprised in the NC1 domain C-terminal amino acid sequence SFSGFLVAPM-COOH (SEQ ID NO: 1), and a method of immunoassay for detecting in a biological sample an epitope in the NC1 domain C-terminal amino acid sequence SFSGFLVAPM-COOH (SEQ ID NO: 1) of collagen type X alpha 1, by contacting the biological sample with the antibody, and determining the amount of binding of the antibody.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.